Analyze Diet
Biological chemistry Hoppe-Seyler1988; 369(5); 397-401; doi: 10.1515/bchm3.1988.369.1.397

Horse urinary kallikrein, II. Effect of subsite interactions on its catalytic activity.

Abstract: The effect of secondary-subsite interactions on the catalytic efficiency of horse urinary kallikrein was studied using as substrates oligopeptides and peptidyl-4-nitroanilides with L-Arg at P1. The known secondary specificity of tissue kallikreins for hydrophobic residues at P2 was also demonstrated for horse urinary kallikrein and a higher preference of this enzyme for L-Phe over L-Leu at P2 was evident. Interaction of subsites S3 with D-Pro and D-Phe enhanced the catalytic efficiency but tripeptidyl-4-nitroanilides with acetyl-D-Pro, L-Pro and acetyl-L-Pro at P3 were no better substrates than acetyl-dipeptidyl-4-nitroanilides. The importance of the leaving group for the catalysis was proved by higher kcat/Km values for the peptides in relation to peptidyl-4-nitroanilides containing a common acyl-chain. The low kcat value for the peptide with L-Pro at P'2 stresses the importance of a hydrogen bond between P'2 amide and the carbonyl group at S'2. One L-arginine residue at the leaving group, specially at the P'2 position, decreases the value of the apparent Km. This effect resulting of side-chain interactions with S'2, is impaired by a second L-Arg at P'1.
Publication Date: 1988-05-01 PubMed ID: 3166744DOI: 10.1515/bchm3.1988.369.1.397Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The researchers in this study evaluated how secondary-subsite interactions influence the efficiency of horse urinary kallikrein, an enzyme, by using different substrates. The researchers found that specific interactions could enhance the enzyme’s efficiency and that certain modifications could negatively impact the enzyme’s performance.

Understanding the Study

  • The paper is centered on understanding the functionality and behavior of an enzyme called horse urinary kallikrein (HUK). This enzyme is one of the many kallikreins, tissue-specific proteases primarily involved in the digestion of proteins.
  • The main goal was to determine how the interactions at the enzyme’s secondary subsites affect its catalytic efficiency. Subsites are the specific areas on an enzyme where substrates (molecules the enzyme acts upon) bind.
  • The Substrates Used

    • The study used oligopeptides and peptidyl-4-nitroanilides with L-Arginine (L-Arg) at what they refer to as subsite P1. L-Arg is an essential amino acid used as substrates.
    • The researchers also used different variations of substrates in this place, such as L-Phenylalanine (L-Phe) and L-Leucine (L-Leu) at subsite P2. This was done to compare and understand the preference and performance of different substrates.
    • Observations and Findings

      • It was observed that horse urinary kallikrein demonstrated a higher preference for substrates with L-Phe over L-Leu at the P2 subsite. This suggests that the nature of substrates used can affect the catalytic efficiency of the enzyme.
      • The research also revealed that the presence of D-Proline (D-Pro) and D-Phenylalanine (D-Phe) at the S3 subsite boosted the catalytic efficiency of the enzyme. However, substrates with acetyl-D-Pro, L-Proline (L-Pro) and acetyl-L-Pro at the P3 subsite did not indicate any increase in efficiency, emphasizing the importance of specific interactions at secondary subsites.
      • The importance of the leaving group in the catalysis was established by higher turnover number to substrate concentration ratio (kcat/Km) values for the peptides compared to those of the peptidyl-4-nitroanilides. These findings suggest that the type of “leaving group” in the reaction significantly impacts the enzyme’s catalytic ability.
      • It was found that the presence of an L-Arginine residue (a version of the amino acid arginine) at the leaving group, especially at the P’2 position, decreases the apparent Km (substrate concentration at which the reaction proceeds at half its maximum rate). However, this effect was impaired when there was a second L-Arg at P’1.

Cite This Article

APA
Araújo-Viel MS, Juliano MA, Oliveira L, Prado ES. (1988). Horse urinary kallikrein, II. Effect of subsite interactions on its catalytic activity. Biol Chem Hoppe Seyler, 369(5), 397-401. https://doi.org/10.1515/bchm3.1988.369.1.397

Publication

ISSN: 0177-3593
NlmUniqueID: 8503054
Country: Germany
Language: English
Volume: 369
Issue: 5
Pages: 397-401

Researcher Affiliations

Araújo-Viel, M S
  • Departamento de Bioquímica, Escola Paulista de Medicina, São Paulo, Brasil.
Juliano, M A
    Oliveira, L
      Prado, E S

        MeSH Terms

        • Animals
        • Binding Sites
        • Horses
        • Kallikreins / isolation & purification
        • Kallikreins / urine
        • Kinetics
        • Protein Binding
        • Substrate Specificity

        Citations

        This article has been cited 5 times.
        1. Fogaça SE, Melo RL, Pimenta DC, Hosoi K, Juliano L, Juliano MA. Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins. Biochem J 2004 Jun 15;380(Pt 3):775-81.
          doi: 10.1042/BJ20031047pubmed: 15040788google scholar: lookup
        2. Nunes VA, Gozzo AJ, Sampaio MU, Juliano MA, Sampaio CA, Araujo MS. Mapping of human plasma kallikrein active site by design of peptides based on modifications of a Kazal-type inhibitor reactive site. J Protein Chem 2003 Aug;22(6):533-41.
        3. Pimenta DC, Chao J, Chao L, Juliano MA, Juliano L. Specificity of human tissue kallikrein towards substrates containing Phe-Phe pair of amino acids. Biochem J 1999 Apr 15;339 ( Pt 2)(Pt 2):473-9.
          pubmed: 10191281
        4. Portaro FC, Cezari MH, Juliano MA, Juliano L, Walmsley AR, Prado ES. Design of kallidin-releasing tissue kallikrein inhibitors based on the specificities of the enzyme's binding subsites. Biochem J 1997 Apr 1;323 ( Pt 1)(Pt 1):167-71.
          doi: 10.1042/bj3230167pubmed: 9173877google scholar: lookup
        5. Chagas JR, Portaro FC, Hirata IY, Almeida PC, Juliano MA, Juliano L, Prado ES. Determinants of the unusual cleavage specificity of lysyl-bradykinin-releasing kallikreins. Biochem J 1995 Feb 15;306 ( Pt 1)(Pt 1):63-9.
          doi: 10.1042/bj3060063pubmed: 7864830google scholar: lookup